TY - JOUR
T1 - Gait Variability in Spinocerebellar Ataxia Assessed Using Wearable Inertial Sensors
AU - Shah, Vrutangkumar V.
AU - Rodriguez-Labrada, Roberto
AU - Horak, Fay B.
AU - McNames, James
AU - Casey, Hannah
AU - Hansson Floyd, Kyra
AU - El-Gohary, Mahmoud
AU - Schmahmann, Jeremy D.
AU - Rosenthal, Liana S.
AU - Perlman, Susan
AU - Velázquez-Pérez, Luis
AU - Gomez, Christopher M.
N1 - Funding Information:
The authors thank all participants for generously donating their time to participate.
Publisher Copyright:
© 2021 International Parkinson and Movement Disorder Society
PY - 2021/12
Y1 - 2021/12
N2 - Background: Quantitative assessment of severity of ataxia-specific gait impairments from wearable technology could provide sensitive performance outcome measures with high face validity to power clinical trials. Objectives: The aim of this study was to identify a set of gait measures from body-worn inertial sensors that best discriminate between people with prodromal or manifest spinocerebellar ataxia (SCA) and age-matched, healthy control subjects (HC) and determine how these measures relate to disease severity. Methods: One hundred and sixty-three people with SCA (subtypes 1, 2, 3, and 6), 42 people with prodromal SCA, and 96 HC wore 6 inertial sensors while performing a natural pace, 2-minute walk. Areas under the receiver operating characteristic curves (AUC) were compared for 25 gait measures, including standard deviations as variability, to discriminate between ataxic and normal gait. Pearson's correlation coefficient assessed the relationships between the gait measures and severity of ataxia. Results: Increased gait variability was the most discriminative gait feature of SCA; toe-out angle variability (AUC = 0.936; sensitivity = 0.871; specificity = 0.896) and double-support time variability (AUC = 0.932; sensitivity = 0.834; specificity = 0.865) were the most sensitive and specific measures. These variability measures were also significantly correlated with the scale for the assessment and rating of ataxia (SARA) and disease duration. The same gait measures discriminated gait of people with prodromal SCA from the gait of HC (AUC = 0.610, and 0.670, respectively). Conclusions: Wearable inertial sensors provide sensitive and specific measures of excessive gait variability in both manifest and prodromal SCAs that are reliable and related to the severity of the disease, suggesting they may be useful as clinical trial performance outcome measures.
AB - Background: Quantitative assessment of severity of ataxia-specific gait impairments from wearable technology could provide sensitive performance outcome measures with high face validity to power clinical trials. Objectives: The aim of this study was to identify a set of gait measures from body-worn inertial sensors that best discriminate between people with prodromal or manifest spinocerebellar ataxia (SCA) and age-matched, healthy control subjects (HC) and determine how these measures relate to disease severity. Methods: One hundred and sixty-three people with SCA (subtypes 1, 2, 3, and 6), 42 people with prodromal SCA, and 96 HC wore 6 inertial sensors while performing a natural pace, 2-minute walk. Areas under the receiver operating characteristic curves (AUC) were compared for 25 gait measures, including standard deviations as variability, to discriminate between ataxic and normal gait. Pearson's correlation coefficient assessed the relationships between the gait measures and severity of ataxia. Results: Increased gait variability was the most discriminative gait feature of SCA; toe-out angle variability (AUC = 0.936; sensitivity = 0.871; specificity = 0.896) and double-support time variability (AUC = 0.932; sensitivity = 0.834; specificity = 0.865) were the most sensitive and specific measures. These variability measures were also significantly correlated with the scale for the assessment and rating of ataxia (SARA) and disease duration. The same gait measures discriminated gait of people with prodromal SCA from the gait of HC (AUC = 0.610, and 0.670, respectively). Conclusions: Wearable inertial sensors provide sensitive and specific measures of excessive gait variability in both manifest and prodromal SCAs that are reliable and related to the severity of the disease, suggesting they may be useful as clinical trial performance outcome measures.
KW - clinical trials
KW - digital biomarker
KW - gait
KW - spinocerebellar ataxia
KW - wearable sensors
UR - http://www.scopus.com/inward/record.url?scp=85113264830&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113264830&partnerID=8YFLogxK
U2 - 10.1002/mds.28740
DO - 10.1002/mds.28740
M3 - Article
C2 - 34424581
AN - SCOPUS:85113264830
SN - 0885-3185
VL - 36
SP - 2922
EP - 2931
JO - Movement Disorders
JF - Movement Disorders
IS - 12
ER -